Coumarin-Thiourea Hybrids Show Potent Carbonic Anhydrase IX and XIII Inhibitory Action.


Journal

ChemMedChem
ISSN: 1860-7187
Titre abrégé: ChemMedChem
Pays: Germany
ID NLM: 101259013

Informations de publication

Date de publication:
20 04 2021
Historique:
received: 24 11 2020
pubmed: 22 12 2020
medline: 12 1 2022
entrez: 21 12 2020
Statut: ppublish

Résumé

A series of coumarin-thiourea hybrids (4 a-o) has been synthesized, and the compounds have been evaluated against the tumour associated transmembrane isoform, human (h) carbonic anhydrase (CA) hCA IX and the less-explored cytosolic isoform, hCA XIII. All compounds exhibited potent inhibition of both isoforms, with K

Identifiants

pubmed: 33346945
doi: 10.1002/cmdc.202000915
doi:

Substances chimiques

Antigens, Neoplasm 0
Carbonic Anhydrase Inhibitors 0
Coumarins 0
CA13 protein, human EC 4.2.1.1
CA9 protein, human EC 4.2.1.1
Carbonic Anhydrase IX EC 4.2.1.1
Carbonic Anhydrases EC 4.2.1.1
Thiourea GYV9AM2QAG

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1252-1256

Informations de copyright

© 2020 Wiley-VCH GmbH.

Références

C. T. Supuran Exp. Opin. Drug Discovery 2020, 15, 671-686.
A. Angeli, F. Carta, C. T. Supuran, Catalysts 2020, 10, 1008.
A. Di Fiore, C. T. Supuran, A. Scaloni, G. De Simone, J. Enzyme Inhib. Med. Chem. 2020, 35, 1450-1461.
R. Ye, C. Tan, B. Chen, R. Li, Z. Mao, Front. Chem. 2020, 8, 402.
V. Alterio, A. Di Fiore, K. D′Ambrosio, C. T. Supuran, G. De Simone, Chem. Rev. 2012, 112, 4421-4468.
S. Pastorekova, R. J. Gillies, Cancer Metastasis Rev. 2019, 38, 65-77.
M. Krasavin, S. Kalinin, T. Sharonova, C. T. Supuran, J. Enzyme Inhib. Med. Chem. 2020, 35, 1555-1561.
C. T. Supuran, J. Y. Winum, Future Med. Chem. 2015, 7, 1407-14.
J. Lau, K. S. Lin, F. Bénard, Theranostics 2017, 7, 4322-4339.
J. Lehtonen, B. Shen, M. Vihinen, A. Casini, A. Scozzafava, C. T. Supuran, A. K. Parkkila, J. Saarnio, A. J. Kivelä, A. Waheed, W. S. Sly, S. Parkkila, J. Biol. Chem. 2004, 279, 2719-27.
J. M. Lehtonen, S. Parkkila, D. Vullo, A. Casini, A. Scozzafava, C. T. Supuran, Bioorg. Med. Chem. Lett. 2004, 14, 3757-3762.
G. De Simone, A. Di Fiore, E. Truppo, E. Langella, D. Vullo, C. T. Supuran, S. M. Monti, J. Enzyme Inhib. Med. Chem. 2019, 34, 1506-1510.
A. Di Fiore, S. M. Monti, M. Hilvo, S. Parkkila, V. Romano, A. Scaloni, C. Pedone, A. Scozzafava, C. T. Supuran, G. De Simone, Proteins 2009, 74, 164-175.
F. Annunziata, C. Pinna, S. Dallavalle, L. Tamborini, A. Pinto, Int. J. Mol. Sci. 2020, 21, 4618.
M. Loncaric, D. Gaso-Sokac, S. Jokic, M. Molnar, Biomolecules 2020, 10, 151.
S. S. Garg, J. Gupta, S. Sharma, D. Sahu, Eur. J. Pharm. Sci. 2020, 152, 105424.
A. Maresca, C. Temperini, H. Vu, N. B. Pham, S. A. Poulsen, A. Scozzafava, R. J. Quinn, C. T. Supuran, J. Am. Chem. Soc. 2009, 131, 3057-62.
A. Maresca, C. Temperini, L. Pochet, B. Masereel, A. Scozzafava, C. T. Supuran, J. Med. Chem. 2010, 53, 335-44.
 
N. Touisni, A. Maresca, P. C. McDonald, Y. Lou, A. Scozzafava, S. Dedhar, J. Y. Winum, C. T. Supuran, J. Med. Chem. 2011, 54, 8271-8277;
A. Sharma, M. Tiwari, C. T. Supuran, J. Enzyme Inhib. Med. Chem. 2014, 29, 292-296.
 
P. S. Thacker, M. Alvala, M. Arifuddin, A. Angeli, C. T. Supuran, Bioorg. Chem. 2019, 86, 386-392;
P. S. Thacker, N. Sridhar Goud, O. S. Argulwar, J. Soman, A. Angeli, M. Alvala, M. Arifuddin, C. T. Supuran, Bioorg. Chem. 2020, 104, 104272;
B. Swain, A. Angeli, P. Singh, C. T. Supuran, M. Arifuddin, Bioorg. Med. Chem. 2020, 28, 115586.
 
R. A. Davis, D. Vullo, C. T. Supuran, S. A. Poulsen, BioMed Res. Int. 2014, 374079;
C. T. Supuran, J. Enzyme Inhib. Med. Chem. 2020, 35, 1462-1470.
K. M. Khan, F. Naz, M. Taha, A. Khan, S. Perveen, M. I. Choudhary, W. Voelter, Eur. J. Med. Chem. 2014, 74, 314-323.
 
C. T. Supuran, A. Nicolae, A. Popescu, Eur. J. Med. Chem. 1996, 31, 431-438;
C. Congiu, V. Onnis, G. Balboni, C. T. Supuran, Bioorg. Med. Chem. Lett. 2014, 24, 1776-1779;
T. A. Fattah, S. Bua, A. Saeed, G. Shabir, C. T. Supuran, Bioorg. Chem. 2019, 82, 123-128.
Z. Zhang, L. Gu, B. Wang, W. Huang, Y. Zhang, Z. Ma, S. Zeng, Z. Shen, J. Enzyme Inhib. Med. Chem. 2019, 808-817.
S. A. Mayekar, A. C. Chaskar, V. V. Mulwad, Synth. Commun. 2009, 40, 46-51.
R. G. Khalifah, J. Biol. Chem. 1971, 246, 2561-2573.
 
H. Kucukbay, N. Bugday, F. Z. Kuçukbay, A. Angeli, G. Bartolucci, C. T. Supuran, J. Enzyme Inhib. Med. Chem. 2020, 35, 489-497;
F. M. Awadallah, S. Bua, W. R. Mahmoud, H. H. Nada, A. Nocentini, C. T. Supuran, J. Enzyme Inhib. Med. Chem. 2018, 33, 629-638.
 
C. T. Supuran, J. Enzyme Inhib. Med. Chem. 2018, 33, 485-495;
A. Di Fiore, G. De Simone, V. Alterio, V. Riccio, J. Y. Winum, F. Carta, C. T. Supuran, Org. Biomol. Chem. 2016, 14, 4853-4858.

Auteurs

Pavitra S Thacker (PS)

Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana State, India.

Danaboina Srikanth (D)

Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana State, India.

Andrea Angeli (A)

Università degli Studi di Firenze, Neurofarba Dept., Sezione di Scienze Farmaceutiche e Nutraceutiche, Via Ugo Schiff 6, 50019, Sesto Fiorentino, Florence, Italy.

Priti Singh (P)

Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana State, India.

Krishna Kartheek Chinchilli (KK)

Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana State, India.

Mohammed Arifuddin (M)

Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana State, India.
Department of Chemistry, Anwarul Uloom College, 11-3-918, New Malleypally, Hyderabad, 500001, Telangana State, India.

Claudiu T Supuran (CT)

Università degli Studi di Firenze, Neurofarba Dept., Sezione di Scienze Farmaceutiche e Nutraceutiche, Via Ugo Schiff 6, 50019, Sesto Fiorentino, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH